Attenuated sympathoadrenal responses, but not severe hypoglycemia, during aggressive glycemic therapy of early type 2 diabetes.
作者信息
Amiel Stephanie A, Cryer Philip E
机构信息
Department of Medicine, King's College London School of Medicine, London, UK.
出版信息
Diabetes. 2009 Mar;58(3):515-7. doi: 10.2337/db08-1647.
Abstract
摘要
相似文献
1
Attenuated sympathoadrenal responses, but not severe hypoglycemia, during aggressive glycemic therapy of early type 2 diabetes.
Diabetes. 2009 Mar;58(3):515-7. doi: 10.2337/db08-1647.
2
[Important therapy goal in diabetics. Intercept hypoglycemias!].
MMW Fortschr Med. 2012 Feb 23;154(3):30, 32. doi: 10.1007/s15006-012-0148-6.
3
The science of hypoglycemia in patients with diabetes.
Curr Diabetes Rev. 2013 May;9(3):195-208. doi: 10.2174/15733998113099990059.
4
Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes.
Diabetes. 2009 Mar;58(3):701-9. doi: 10.2337/db08-1230. Epub 2008 Dec 10.
5
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Diabetes. 2002 Mar;51(3):724-33. doi: 10.2337/diabetes.51.3.724.
6
Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
Diabetes Care. 1999 Jul;22(7):1144-50. doi: 10.2337/diacare.22.7.1144.
7
Hypoglycemic symptom variation is related to epinephrine and not peripheral muscle sympathetic nerve response.
J Diabetes Complications. 1997 Jan-Feb;11(1):15-20. doi: 10.1016/1056-8727(95)00082-8.
8
Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Ann Intern Med. 2012 Sep 4;157(5):336-47. doi: 10.7326/0003-4819-157-5-201209040-00508.
9
[Hypoglycemia--simply annoying or dangerous?].
MMW Fortschr Med. 2016 Jun 9;158(11):67-70. doi: 10.1007/s15006-016-8385-8.
引用本文的文献
1
Role of the Adrenal Medulla in Hypoglycaemia-Associated Autonomic Failure-A Diabetic Perspective.
Metabolites. 2024 Jan 31;14(2):100. doi: 10.3390/metabo14020100.
2
Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes management.
Diabetes Ther. 2011 May;2(2):51-66. doi: 10.1007/s13300-010-0018-0. Epub 2011 Feb 8.
本文引用的文献
1
Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes.
Diabetes. 2009 Mar;58(3):701-9. doi: 10.2337/db08-1230. Epub 2008 Dec 10.
2
Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control.
Diabetes. 2009 Feb;58(2):360-6. doi: 10.2337/db08-1153. Epub 2008 Dec 3.
3
The barrier of hypoglycemia in diabetes.
Diabetes. 2008 Dec;57(12):3169-76. doi: 10.2337/db08-1084.
4
10-year follow-up of intensive glucose control in type 2 diabetes.
N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.
5
Intensive glycemic control in the ACCORD and ADVANCE trials.
N Engl J Med. 2008 Jun 12;358(24):2630-3. doi: 10.1056/NEJMe0804182. Epub 2008 Jun 6.
6
Hypoglycaemia in Type 2 diabetes.
Diabet Med. 2008 Mar;25(3):245-54. doi: 10.1111/j.1464-5491.2007.02341.x. Epub 2008 Jan 21.
7
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
Diabetologia. 2007 Jun;50(6):1140-7. doi: 10.1007/s00125-007-0599-y. Epub 2007 Apr 6.
8
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
N Engl J Med. 2005 Dec 22;353(25):2643-53. doi: 10.1056/NEJMoa052187.
9
Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities.
Diabetes Care. 2005 Dec;28(12):2948-61. doi: 10.2337/diacare.28.12.2948.
10
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
Diabet Med. 2005 Jun;22(6):749-55. doi: 10.1111/j.1464-5491.2005.01501.x.
Zotero 插件